Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey Australia hire new MD

Sudler & Hennessey (S&H) have appointed Jack Blakey as managing director of their operation in Australia

Global healthcare marketing and communications organisation, Sudler & Hennessey, have appointed Jack Blakey as managing director of their operation in Australia.

The news follows the promotion of Max Jackson to CEO of both S&H's Europe/Middle East/Africa (EMEA) and Asia Pacific (APAC) regions.

Max Jackson, CEO of the S&H EMEA and APAC regions, said: "We have been looking for an exceptional individual who can work with our talented team to continue to deliver the work that our clients expect. I am delighted to announce we have successfully completed that search with the appointment of Jack. With his depth and breadth of proven talents and skills, Jack can deliver an exciting new chapter in the agency's already successful history."

Prior to joining S&H, Blakey had been running his own agency, Marrow, whose major clients include AstraZeneca and Roche as well as health related brands in food, financial services and publishing. 

18th February 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....